Method and apparatus to prevent medication error in a networked infusion system

    公开(公告)号:AU2004226440A1

    公开(公告)日:2004-10-14

    申请号:AU2004226440

    申请日:2004-03-24

    Applicant: BAXTER INT

    Abstract: Systems and methods are provided for preventing delivery of a nontherapeutic dose of medication to a patient and/or preventing medications from being administered to the patient that causes documented allergic or drug sensitivity reactions to the patient. The networked medication delivery system [20] includes an infusion device [22] programmable by the user with instructions for administering the medication, and a computing device [26] for determining whether the programmed data would yield a clinically acceptable dose or the medication is in the list of documented medication that would cause an allergic or drug sensitivity reaction to the patient. The system may also include at least one monitor [24] for displaying at least a portion of the programmed data, and an alerting device [28] for notifying medical personnel when the inputted dosage data are determined to yield a clinically unacceptable dose or the medication is in the list of documented medications that would cause an allergic or drug sensitivity to the patient. The infusion device may be configured to become deactivated to prevent delivery of the medication, when the dose is outside the therapeutic range or to prevent mediation of documented allergic or drug sensitivity to a patient is delivered to the patient. Also included is a database [27] that may be remotely situated from the system [20] and accessed via a network [30].

    Method and apparatus to prevent medication error in a networked infusion system

    公开(公告)号:AU2004226440B2

    公开(公告)日:2008-09-25

    申请号:AU2004226440

    申请日:2004-03-24

    Applicant: BAXTER INT

    Abstract: Systems and methods are provided for preventing delivery of a nontherapeutic dose of medication to a patient and/or preventing medications from being administered to the patient that causes documented allergic or drug sensitivity reactions to the patient. The networked medication delivery system [20] includes an infusion device [22] programmable by the user with instructions for administering the medication, and a computing device [26] for determining whether the programmed data would yield a clinically acceptable dose or the medication is in the list of documented medication that would cause an allergic or drug sensitivity reaction to the patient. The system may also include at least one monitor [24] for displaying at least a portion of the programmed data, and an alerting device [28] for notifying medical personnel when the inputted dosage data are determined to yield a clinically unacceptable dose or the medication is in the list of documented medications that would cause an allergic or drug sensitivity to the patient. The infusion device may be configured to become deactivated to prevent delivery of the medication, when the dose is outside the therapeutic range or to prevent mediation of documented allergic or drug sensitivity to a patient is delivered to the patient. Also included is a database [27] that may be remotely situated from the system [20] and accessed via a network [30].

    METHOD AND APPARATUS TO PREVENT MEDICATION ERROR IN A NETWORKED INFUSION SYSTEM

    公开(公告)号:CA2516681A1

    公开(公告)日:2004-10-14

    申请号:CA2516681

    申请日:2004-03-24

    Applicant: BAXTER INT

    Abstract: Systems and methods are provided for preventing delivery of a nontherapeutic dose of medication to a patient and/or preventing medications from being administered to the patient that causes documented allergic or drug sensitivity reactions to the patient. The networked medication delivery system [20] includes an infusion device [22] programmable by the user with instructions for administering the medication, and a computing device [26] for determining whether the programmed data would yield a clinically acceptable dose or the medication is in the list of documented medication that would cause an allergic or drug sensitivity reaction to the patient. The system may also include at least one monitor [24] for displaying at least a portion of the programmed data, and an alerting device [28] for notifying medical personnel when the inputted dosage data are determined to yield a clinically unacceptable dose or the medication is in the list of documented medications that would cause an allergic or drug sensitivity to the patient. The infusion device may be configured to become deactivated to prevent delivery of the medication, when the dose is outside the therapeutic range or to prevent mediation of documented allergic or drug sensitivity to a patient is delivered to the patient. Also included is a database [27] that may be remotely situated from the system [20] and accessed via a network [30].

    Method and apparatus to prevent medication error in a networked infusion system

    公开(公告)号:NZ542131A

    公开(公告)日:2006-09-29

    申请号:NZ54213104

    申请日:2004-03-24

    Applicant: BAXTER INT

    Abstract: Systems and methods for preventing delivery of a non-therapeutic dose of medication to a patient and/or preventing medications from being administered that would cause documented allergic or drug sensitivity reactions to the patient are disclosed. The networked medication delivery system 20 includes an infusion device 22 programmable by the user with instructions for administering the medication, and a computing device 26 for determining whether the programmed data would yield a clinically acceptable dose or whether the medication is in the list of documented medication that would cause an allergic or drug sensitivity reaction to the patient. The system may also include at least one monitor for displaying at least a portion of the programmed data, and an alerting device 28 for notifying medical personnel when the inputted dosage data are determined to yield a clinically unacceptable dose or when the medication is in the list of documented medications that would cause an allergic or drug sensitivity to the patient. The infusion device may be configured to become deactivated to prevent delivery of the medication when the dose is outside the therapeutic range or to prevent delivery of medication of documented allergic or drug sensitivity to a patient. Also included is a database 2) that may be remotely situated from the system 20 and accessed via a network 30.

Patent Agency Ranking